Patrick T Gunning completed his BSc honours and PhD in chemistry with Andrew Benniston and Robert Peacock at the University of Glasgow. Gunning pursued post-doctoral studies at Yale University under the mentorship of Andrew Hamilton. In 2007, he accepted an assistant professorship position at the University of Toronto, Mississauga Department of Chemistry. In the last 8 years he has developed a dynamic and diverse medicinal chemistry program targeting protein-protein interactions, a most challenging of targets. Moreover, Gunning’s team develop inhibitors of proteins that drive the most rare and lethal of human cancers, including glioblastoma, acute myeloid leukemia, multiple myeloma, and refractory medullablastoma. This work has lead to several advanced preclinical candidates against a range of human disease. In addition to medicinal chemsitry, His group is developing novel fluorescent molecular recognition scaffolds for early detection of human disease including Alzheimer’s and Parkinson’s disease. Gunning has been recognized with numerous awards including the 2013 University of Toronto Inventors of the Year Award, The 2012 Royal Society for Chemistry’s MedChemComm Emerging Researcher Award, as well as being noted as one of the Top 10 to watch by the Toronto Star in 2013.
Patrick T. Gunning
University of Toronto